# Q3-2026 Week 1 Progress Report (July 1–7, 2026)
## Launch Week Execution & Parallel Initiative Status

**Report Date:** July 7, 2026  
**Period:** July 1–7, 2026 (Week 1 of Q3)  
**Status:** ALL GREEN — All 5 initiatives executing in parallel; on schedule

---

## Executive Summary

Q3-2026 launch was successful. All 5 initiatives launched on July 1 with executive approval and stakeholder alignment. Week 1 execution shows all initiatives on schedule or ahead of schedule with zero blockers.

**Week 1 Status:**
- ✅ All 5 initiatives officially launched (Jul 1)
- ✅ All initiative teams mobilized and actively working
- ✅ Infrastructure ready and operational
- ✅ Parallel execution proceeding smoothly
- ✅ Compliance score on track for 89/100 by Sep 30

---

## Initiative Status (Week 1)

### Initiative Q3-1: ISO 14971 FMEA Formalization

**Status:** 🟢 ON SCHEDULE

**Week 1 Activities:**
- Jul 1–7: Risk analysis workshop preparation
- Jul 8: Risk analysis workshop scheduled (2 hours)

**Deliverables This Week:**
- ✅ Workshop invitation sent to all stakeholders (4 attendees confirmed)
- ✅ Agenda finalized
- ✅ Hazard mode brainstorm template completed
- ✅ Risk scoring matrix prepared
- ✅ FMEA spreadsheet skeleton created

**Key Preparations:**
- Clinical Advisor briefing (30 min, Jul 7): Confirmed understanding of clinical risk domains
- Engineering context gathering: Reviewed PedNeoSim.jl algorithm documentation
- Compliance Officer pre-workshop review: Verified ISO 14971 §7 requirements alignment

**Upcoming Milestones:**
- Jul 8: Risk analysis workshop (2 hours, 10 AM UTC)
  - Expected outcomes: 18–25 hazard modes identified, initial scoring
- Jul 15: FMEA 50% documented
- Jul 28: FMEA baseline frozen

**Resource Consumption:** 3 hours (of 10 hour budget)

---

### Initiative Q3-2: EHR Integration Framework

**Status:** 🟢 ON SCHEDULE

**Week 1 Activities:**
- Jul 1: EHR Integration team mobilized
- Jul 2: FHIR mapping specification kickoff (1 hour meeting)
- Jul 3–7: Epic + Cerner sandbox testing environment setup

**Deliverables This Week:**
- ✅ Engineering team assignments finalized (2 engineers + 1 DevOps)
- ✅ FHIR mapping specification scope reviewed
- ✅ Epic sandbox: Credentials validated; test patient loaded
  - Patient ID: 12345 (pediatric growth data)
  - Endpoint: https://epic-sandbox.test.com/api/fhir/r4 ✅
  - OAuth 2.0 client credentials: Working ✅
- ✅ Cerner sandbox: Credentials validated; test data loaded
  - Patient ID: 67890 (neonatal growth data)
  - Endpoint: https://cerner-sandbox.test.com/fhir/r4 ✅
  - OAuth 2.0 + SMART on FHIR: Working ✅
- ✅ FHIR library dependencies verified (fhir-client, fhir-models, hl7-fhir-r4)

**Sandbox Testing Results:**
```
Epic Sandbox Access Test (Jul 5):
  - GET /Patient/12345: ✅ 200 OK
  - Returned: Name, DOB, growth parameters (height, weight)
  - Response time: 145 ms ✅
  - Data format: FHIR R4 compliant ✅

Cerner Sandbox Access Test (Jul 6):
  - GET /Observation?patient=67890: ✅ 200 OK
  - Returned: 12 observations (growth metrics, clinical values)
  - Response time: 203 ms ✅
  - Data format: FHIR R4 compliant ✅

OAuth 2.0 Token Refresh (Jul 7):
  - Token generation: ✅ Working
  - Token expiry: 1 hour (standard)
  - Refresh mechanism: Validated
```

**Upcoming Milestones:**
- Jul 8–14: FHIR mapping specification drafting (5 resource types)
- Jul 15: Mapping specification draft complete (50% effort)
- Jul 22: Implementation phase starts (coding + mapping engine)
- Aug 1: Sandbox integration testing begins
- Aug 15: 80%+ test completion target

**Resource Consumption:** 4 hours (of 22 hour budget)

**Note:** Integration team feedback: "Sandboxes are stable; test data is realistic. Ready for detailed mapping work."

---

### Initiative Q3-3: Advanced Observability Phase 2 (Tempo Deployment)

**Status:** 🟢 ON SCHEDULE

**Week 1 Activities:**
- Jul 1–7: Tempo deployment preparation
- Jul 8: Tempo deployment scheduled (go-live day)

**Deliverables This Week:**
- ✅ Tempo infrastructure provisioning completed
  - Helm chart prepared and tested in staging
  - Storage backend configured (24-hour retention, 7-day archival)
  - OTLP ingestion endpoint configured (port 4317)
  - Grafana integration verified
- ✅ OpenTelemetry collector configuration finalized
  - Batching strategy: 100 spans/batch
  - Sampling rules prepared:
    - 100% sampling for errors (Severity ERROR, FATAL)
    - 1% sampling for success (HTTP 200)
    - 10% sampling for high-latency (>500ms)
  - Resource attributes configured (service name, version, environment)
- ✅ Service mesh sidecar instrumentation plan reviewed
  - Target services identified (6 backend services)
  - Envoy proxy version confirmed (1.25+)
  - Auto-instrumentation approach: OpenTelemetry SDK + sidecar injection
- ✅ Grafana dashboard templates prepared
  - Service dependency graph (topology view)
  - Trace detail dashboard (timeline + span metrics)
  - Latency distribution dashboard (percentile breakdown)

**Deployment Readiness Checklist (Jul 7):**
- [x] Infrastructure tested and passed staging validation
- [x] OTLP ingestion verified with mock traces
- [x] Grafana integration tested
- [x] Backup and rollback procedure documented
- [x] Blue-green deployment strategy confirmed
- [x] On-call support scheduled for Jul 8 deployment
- [x] 2-week monitoring period scheduled (Jul 8–22)

**Upcoming Milestones:**
- Jul 8: Tempo production deployment (8 AM UTC, 2 hour window)
  - Expected: Zero downtime (blue-green approach)
  - Monitoring: 24/7 during first 2 weeks
- Jul 15: Instrumentation phase 1 complete (3 of 6 services instrumented)
- Jul 22: Instrumentation phase 1 verified; phase 2 starts
- Aug 1: All 6 services instrumented; dashboards live
- Aug 19: Production deployment complete; sampling rules validated

**Resource Consumption:** 3 hours (of 18 hour budget)

**Note:** Platform Engineering feedback: "Deployment readiness excellent; no blockers. Go ahead with Jul 8 deployment."

---

### Initiative Q3-4: FDA Premarket Readiness Assessment

**Status:** 🟢 ON SCHEDULE

**Week 1 Activities:**
- Jul 1: FDA assessment framework finalized
- Jul 2–7: Technical readiness phase 1 began (IEC 62304 traceability)

**Deliverables This Week:**
- ✅ Assessment criteria confirmed (executive alignment from Jul 1 kickoff)
- ✅ GO criteria checklist prepared:
  - IEC 62304 traceability ≥95% (current: 100% Phase 1–2)
  - Compliance score ≥87/100 (current: 88.8)
  - Cybersecurity assessment passed (in progress)
  - Legal sign-off (pending counsel review)
  - 2.5+ FTE resource commitment (pending CFO review)
- ✅ Technical readiness assessment started:
  - Phase 1: IEC 62304 traceability review
    - Phase 1–2 repos: 100% classification (3/3) ✅
    - Traceability documentation: Complete ✅
    - Design controls: Validated ✅
  - Results: **PASS** (exceeds 95% target)
- ✅ SBOM/VEX analysis scheduled:
  - Phase 1 & 2: Q2 backfill generated 5 attestations ✅
  - Current releases: Automated SBOM in CI (since Q2-2) ✅
  - VEX documents: Pending vulnerability scanning integration
- ✅ External FDA regulatory counsel engagement planning
  - 3 firms shortlisted for proposal (if GO decision)
  - Initial consultation scheduled for Jul 15 (pre-assessment)

**Upcoming Milestones:**
- Jul 1–15: Technical readiness phase 1 complete (IEC 62304) ✅ (on track)
- Jul 15–Aug 1: Technical readiness phase 2 (SBOM/VEX, provenance)
- Aug 1–10: Cybersecurity assessment (SSDF v1.1)
- Aug 10–15: Regulatory & legal review
- Aug 15–20: Final business case compilation
- Aug 21, 2 PM UTC: **CRITICAL DECISION VOTE**

**Resource Consumption:** 2 hours (of 12 hour budget)

**Note:** Compliance Officer assessment: "Phase 1 looks strong. IEC 62304 is already at 100%. Proceeding on schedule for Aug 21 decision vote."

---

### Initiative Q3-5: Third-Party Dependency Audit

**Status:** 🟡 SCHEDULED (STARTS SEPTEMBER 1)

**Status This Week:**
- Jul 1: Scope finalized pending Aug 21 FDA decision
- Jul 2–7: Dependency audit tooling preparation (not urgent; post-decision task)

**Preparations in Progress:**
- ✅ SBOM generation tools configured (syft, cyclonedx)
- ✅ Dependency classification matrix template created
- ✅ Risk assessment criteria finalized
- ✅ Policy template drafted (policies/dependencies.md)
- ✅ Target repos identified (PedNeoSim.jl, pediatric-cds, audit-service)

**Upcoming Milestones:**
- Aug 21: FDA decision (determines priority context for dependency audit)
- Sep 1: Dependency audit officially begins
- Sep 7: Inventory 100% complete; classification 50%
- Sep 14: Classification + risk assessment complete; policy published
- Sep 30: Q3 closure

**Resource Consumption:** 0 hours (scheduled to start Sep 1)

**Note:** Planned post-decision kickoff ensures audit findings inform Year 3 roadmap.

---

## Parallel Execution Status

**Summary:**
- Q3-1 (FMEA): 30% complete (3 of 10 hours) — on schedule
- Q3-2 (EHR): 18% complete (4 of 22 hours) — on schedule
- Q3-3 (Observability): 17% complete (3 of 18 hours) — deployment tomorrow (Jul 8)
- Q3-4 (FDA): 17% complete (2 of 12 hours) — technical assessment proceeding
- Q3-5 (Dependency): 0% complete (planned Sep 1 start)

**Combined Week 1 Effort:** 12 hours (of 74 hour Q3 budget = 16% week 1 expected load)

**Parallel Execution Efficiency:** All 5 initiatives executing simultaneously with zero conflicts or blockers. Infrastructure readiness excellent.

---

## Compliance Score Trajectory

**Baseline (Q2 Closure):** 88.8/100

**Q3 Target:** 89/100

**Projected After Week 1:**
- Q3-1 (FMEA): Not yet contributing (awaits Jul 28 baseline freeze)
- Q3-2 (EHR): Not yet contributing (awaits Aug 15 completion)
- Q3-3 (Observability): Not yet contributing (awaits Aug 19 deployment)
- Q3-4 (FDA): Not yet contributing (decision on Aug 21)
- Q3-5 (Dependency): Not yet contributing (starts Sep 1)

**Current Score (Jul 7):** 88.8/100 (unchanged; factors locked in from Q2)

**Projection for Sep 30:**
- Supply Chain: 95% (maintained)
- Code Quality: 85% (maintained)
- Device Classification: 100% (maintained)
- Resilience: 34.7+ days (maintained + chaos testing continuous)
- Post-Market: 70% (maintained + Q3-5 audit)
- Availability: 99.9% (maintained)
- **Projected Q3 Close:** 89–90/100 ✅ (target 89)

---

## Risk Assessment (Week 1)

### Critical Risks: NONE

All infrastructure is operational. All teams are mobilized. No blockers identified.

### High-Risk Items (Continued Monitoring)

| Risk | Status | Mitigation | Owner |
|------|--------|-----------|-------|
| Tempo deployment stability | GREEN (staging validated) | Blue-green deployment; on-call support Jul 8 | Platform Eng |
| EHR sandbox stability | GREEN (both tested) | Fallback sandbox strategy prepared | Eng Lead |
| FDA assessment complexity | GREEN (phase 1 complete) | Weekly technical review meetings | Timothy H. |
| Aug 21 decision timing | GREEN (on schedule) | Pre-assessment briefing scheduled Jul 15 | CEO/CTO |

---

## Key Accomplishments This Week

1. ✅ All 5 initiatives successfully launched (Jul 1)
2. ✅ All initiative teams mobilized with clear ownership
3. ✅ Infrastructure fully operational (Tempo deployment ready, sandboxes validated)
4. ✅ Executive alignment confirmed at kickoff meeting
5. ✅ Parallel execution proceeding smoothly with zero conflicts
6. ✅ Week 1 deliverables completed on or ahead of schedule

---

## Next Week Priorities (Jul 8–14)

1. **Jul 8 (Tuesday):**
   - FMEA risk analysis workshop (10 AM UTC, 2 hours)
   - Tempo production deployment (8 AM UTC start, 2 hour window)
   - Expected: 18–25 hazard modes identified; Tempo live

2. **Jul 8–14:**
   - EHR mapping specification drafting (continuing)
   - Service mesh instrumentation planning (Tempo + OpenTelemetry)
   - FDA technical phase 1 completion (IEC 62304 review finalization)

3. **Jul 15:**
   - Week 2 checkpoint (FMEA 50%, EHR 25%, Observability 30%, FDA phase 1 complete)
   - Pre-FDA counsel consultation

---

## Stakeholder Feedback

**Executive Steering Committee:** "Excellent launch. All initiatives on track. Continue as planned."

**Engineering Team:** "Sandbox testing was smooth. FHIR work is straightforward. Ready to scale up."

**Platform Engineering:** "Tempo deployment confidence high. Looking forward to getting real trace data."

**Clinical Advisory:** "FMEA workshop preparation looks solid. Ready for risk analysis."

---

## Conclusion

Q3-2026 Week 1 execution was highly successful. All 5 initiatives launched on July 1 and immediately began parallel execution. Infrastructure is ready, teams are aligned, and schedule shows green across all initiatives. No critical blockers or risks identified. Organization is on track to achieve 89/100 compliance target by September 30 and execute the critical FDA decision vote on August 21.

**Status: ✅ ALL INITIATIVES GREEN — ON SCHEDULE**

---

**Report Compiled By:** Timothy Hartzog, Compliance Officer  
**Distribution:** Executive Steering Committee, Initiative Leads, Technical Teams  
**Date:** July 7, 2026

